Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-06

FDA Approved: XACIATO — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for XACIATO, a clindamycin phosphate vaginal gel from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XACIATO (CLINDAMYCIN PHOSPHATE)

Snippet

SUPPL AP for XACIATO (CLINDAMYCIN PHOSPHATE)